BrunoSan Finance Intelligence · May 24, 2026
Finance Intelligence News
Every article includes an Intel Score breakdown — so you know exactly how strong each signal is and where it came from. Not editorial judgment. Signal mathematics.
🏦 RATE DECISION
1.000
Yield Curve Inversion Deepens as Iran De-escalation Hopes Create Federal Reserve Policy Paradox
Hopes for a diplomatic resolution with Iran have sent crude oil prices tumbling, creating a policy dilemma that has markets pricing in a deeper yield curve inversion; the 10Y-2Y spread has compressed by 20 bps to -15 bps on expectations of a hawkish near-term Federal Reserve response to sticky core inflation.
📊 EARNINGS
1.000
Citigroup's Private Credit Pivot and Deal Flow Signal Undervalued Earnings Power
Citigroup's strategic pivot into private credit, marked by a new $12 billion direct lending initiative, and its execution on major advisory deals are fundamentally reshaping its earnings profile, creating a valuation opportunity for investors who can look past the restructuring noise.
📊 EARNINGS
1.000
A Closer Look at Labcorp's Valuation Following Q1 Earnings Beat and Strategic Tech Investments
Labcorp Holdings reported Q1 2026 adjusted EPS of $3.95, beating consensus by 3.9%, driven by strong growth in specialty diagnostics and early efficiencies from its new AI platform, signaling a potential re-rating of its valuation multiples.
🏦 RATE DECISION
1.000
This Bond Strategy Uses Macaulay Duration to Immunize Portfolios Against Rate Hikes
Matching a bond portfolio's holding period to its Macaulay duration—for example, 8.4 years for a 10-year Treasury note with a 4.5% coupon and a 4.75% yield—creates an immunization point where price losses from rate hikes are precisely offset by higher reinvestment income, neutralizing interest rate risk for that specific time horizon.